Pillstats
Rx only · Tablet, Film Coated · Oral

Lacosamide

Brands: Vimpat · Lacosamide

23 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US91 NDCs
23 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers23 labelers
Packages232
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 63 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.733$1.47$2.20$2.93Dec 2025Mar 2026Jun 2026
$2.379
Latest avg · Jun 17, 2026
-4%
Since Dec 17, 2025
23
Active US suppliers
29%
Top-2 supplier share*

Who makes it23 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown36SUPPLYING
Alembic Pharmaceuticals Limitedunknown32SUPPLYING
Ascend Laboratories, LLCunknown16SUPPLYING
Camber Pharmaceuticals, Inc.unknown16SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown12SUPPLYING
UCB, Inc.unknown12SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown12SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown12SUPPLYING
REMEDYREPACK INC.repackager8SUPPLYING
Aurobindo Pharma Limitedunknown8SUPPLYING
Kanchan Healthcare Incunknown8SUPPLYING
MSN Laboratories Private Limitedunknown8SUPPLYING
Macleods Pharmaceuticals Limitedunknown8SUPPLYING
Breckenridge Pharmaceutical, Inc.unknown8SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown8SUPPLYING

+ 8 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.